Weread with interest the case report by Shinohara et al (1) and the editorial by Takizawa and Ito (2). Shinohara et al described a case of rapidly progressive interstitial lung disease associated with dermatomyositis (DM) who was successfully treated with cyclophosphamide pulse therapy. The case report and the editorial by Takizawa et al commenton the use of cyclosporine for this intractable interstitial lung disease. Wewould like to point out that we published an article concerning the use of cyclosporine for interstitial pneumonitis associated with dermatomyositis/polymyositis (PM) in ScandJRheumatol (3).
Ourconclusion wasthat cyclosporine is effective against both myositis and interstitial pneumonitis when used early in the course of the disease. Although we treated three cases of interstitial pneumonitis associated with DM/PMwho did die due to respiratory failure before 1 991 , four cases who were treated with cyclosporine early in the course of the disease after 1 992 are still alive. Andone of the four cases was thought to be a case of rapidly progressive interstitial lung disease associated with DM.Weagree that a prospective trial is important to obtain a definitive result, but we could prove the effectiveness of cyclosporine by comparing with our previous cases.
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